Tirzepatide Peptide (GLP1-T)

Welcome to Buy Peptides Online USA, your premier domestic source for high-purity research peptides designed for serious scientific investigations. This product is intended strictly for laboratory research use only and is not for human or veterinary consumption. It is not a medicine, drug, or medical device and has not been evaluated by the FDA.

A Breakthrough in Dual Receptor Agonism: An Introduction to Tirzepatide Peptide 🔬

For researchers focused on the frontiers of metabolic disease, obesity, and systemic inflammation, Tirzepatide (LY3298176) stands as one of the most significant and extensively studied peptide molecules of the 21st century. This synthetic 39-amino acid peptide is a first-in-class, dual agonist that uniquely and potently activates both the glucose-dependent insulinotropic polypeptide receptor (GIPR) and the glucagon-like peptide-1 receptor (GLP-1R) .

Tirzepatide's significance in research stems from its balanced dual agonism, which distinguishes it from earlier single-receptor therapies. By simultaneously targeting both incretin pathways, it harnesses synergistic effects on insulin secretion, appetite suppression, energy expenditure, and metabolic regulation . This "twincretin" approach has demonstrated superior efficacy in glycemic control and weight reduction compared to selective GLP-1 agonists like semaglutide, representing a paradigm shift in metabolic therapeutics .

A very recent 2025 study published in Nature Metabolism utilized novel fluorescent markers (daLUXendins) to visualize tirzepatide's mode of action, demonstrating that it binds primarily to pancreatic beta cells, but also to alpha and delta cells, and activates specific nerve cells and tanycytes in the brain crucial for appetite control . Beyond its well-documented metabolic effects, a comprehensive 2025 PubMed review highlights its emerging therapeutic potential across a range of conditions, including cardiovascular health, metabolic-associated fatty liver disease (MAFLD), chronic kidney disease (CKD), and neurological disorders such as Alzheimer's and Parkinson's diseases .

What is Tirzepatide Peptide?

Tirzepatide is a synthetic 39-amino acid peptide with the sequence YXEGTFTSDY SIXLDKIAQK AFVQWLIAGG PSSGAPPPS, incorporating non-coded amino acids including Aib . It features a C20 fatty diacid moiety attached to a lysine residue, which facilitates albumin binding and extends its circulating half-life . Its molecular formula is C₂₂₅H₃₄₈N₄₈O₆₈ with a molecular weight of approximately 4813.45 Da . It is identified by CAS number 2023788-19-2 .

Its primary mechanisms of action, established through extensive research, include:

1. Dual GIP and GLP-1 Receptor Agonism: Tirzepatide potently activates both GIP and GLP-1 receptors, with a balanced and biased agonism that leads to synergistic improvements in glycemic control and energy homeostasis . GIP agonism complements GLP-1 activity by enhancing insulin secretion and potentially attenuating some of the gastrointestinal side effects associated with pure GLP-1 agonists .
2. Regulation of Appetite and Food Intake: By activating receptors in key hypothalamic and brainstem regions involved in energy balance, tirzepatide reduces appetite, increases satiety, and leads to substantial and sustained weight loss .
3. Glucose-Dependent Insulin Secretion and Beta-Cell Function: Tirzepatide enhances glucose-dependent insulin secretion from pancreatic beta-cells, improves insulin sensitivity, and has been shown to positively impact beta-cell function and health .
4. Anti-Inflammatory and Systemic Effects: The dual agonist activity addresses multiple pathophysiological pathways, including insulin resistance, inflammation, and oxidative stress, which underpin its potential benefits in cardiovascular, renal, and neurodegenerative conditions .

🔬 Primary Research Focuses and Applications

The Tirzepatide Peptide is at the forefront of multiple cutting-edge research areas, validated by numerous peer-reviewed studies including very recent 2025 publications:

• Obesity and Weight Management Research: Tirzepatide is a premier tool for studying pharmacological weight loss. The SURMOUNT clinical trial program has demonstrated unprecedented efficacy. In adults without diabetes, tirzepatide (10-15 mg/week) produced mean weight loss of 20-21% at 72 weeks, with 78-84% of patients losing at least 10% of their body weight (NNT=2 vs. placebo) . In adults with type 2 diabetes and obesity, weight loss ranged from 13-15% at 72 weeks .

• Type 2 Diabetes and Glycemic Control Research: The SURPASS trials have shown that tirzepatide leads to superior glycemic control compared to selective GLP-1 agonists, with mean HbA1c reductions of 1.8-2.6% . A 2025 open-label RCT demonstrated that tirzepatide resulted in 20% weight loss compared to 14% for semaglutide at 72 weeks in patients without diabetes .

• Type 1 Diabetes Research (2025 Breakthrough): A landmark Phase 2, 12-week randomized controlled trial published in Diabetes Care (November 2025) investigated tirzepatide in adults with type 1 diabetes and obesity (BMI >30 kg/m2). The results showed a mean weight loss of 8.8% in the tirzepatide group vs. placebo (treatment difference -8.7 kg), with 100% and 45% of participants achieving ≥5% and ≥10% weight loss respectively. Tirzepatide also improved HbA1c (mean difference -0.4%) and reduced total daily insulin dose by 35.1% .

• Neuroprotection and Neurodegenerative Disease Research (2025 Review): A comprehensive 2025 PubMed review highlights tirzepatide's potential to address pathophysiological pathways common to metabolic and neurodegenerative disorders, including inflammation and oxidative stress. This opens new avenues for research into its application for Alzheimer's and Parkinson's diseases .

• Cardiovascular, Hepatic, and Renal Research: The 2025 review also synthesizes evidence on tirzepatide's broader therapeutic spectrum, including potential benefits in cardiovascular health, metabolic-associated fatty liver disease (MAFLD), and chronic kidney disease (CKD) .

🧪 Product Specifications & Technical Data

At Buy Peptides Online USA, we ensure your research is built on a foundation of quality and consistency. This peptide is manufactured to rigorous laboratory standards and verified through advanced analytical methods.

✅ Why Choose Buy Peptides Online USA for Your Research?

Sourcing reliable research compounds is critical for reproducible, high-impact science. Here is why discerning researchers across the USA trust us:

• Verified Purity & Potency: We provide access to Certificates of Analysis (COA) and rely on advanced analytical methods like High Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to confirm the identity and purity (≥99%) of every batch . This commitment ensures the integrity of your experimental data.
• Research-Focused Integrity: We strictly adhere to research-use-only (RUO) guidelines. Our product descriptions are factual, focusing on chemical properties and cited research applications, never unverified human-use claims. This product is not for diagnostic or therapeutic use.
• Fast & Discreet USA Shipping: As a USA-based supplier, we offer fast, reliable shipping across the United States with discreet packaging to ensure your order arrives safely, professionally, and on time for your critical research timelines. Enjoy free shipping on orders over $300.
• Expert Support & Authenticity Guarantee: Our team provides technical consultation to support your work. We stand behind the authenticity and quality of all our products, offering a product replacement service and clear complaint handling.

📝 Handling, Storage, & Important Safety Information

• Critical Storage Information: Upon receipt, store the lyophilized powder at -20°C (-4°F) or below, desiccated, protected from light and moisture. It is stable for up to 3 years under these conditions .
• Handling for Research Use: This product is for laboratory use only by qualified professionals. Before opening, allow the vial to warm to room temperature and briefly centrifuge to concentrate material at the bottom. Reconstitute in sterile, ultra-pure water to achieve desired concentration. Gently invert to mix; do not vortex.
• Stability Considerations: Once reconstituted, for short-term storage, keep at 2-8°C. For long-term storage, aliquot and freeze at -20°C or below. Avoid repeated freeze-thaw cycles at all costs, as this can degrade the peptide and reduce its bioactivity.
• Safety Considerations: Tirzepatide is a potent, bioactive peptide for research use only. In clinical trials, the most common adverse effects were dose-dependent gastrointestinal events (nausea, vomiting, diarrhea, decreased appetite) . Always wear appropriate personal protective equipment (PPE), including lab coats, safety glasses, and nitrile gloves. Work in a laminar flow hood or well-ventilated area.
• Warning: This product is not for human or veterinary use. It is not a drug, food, or cosmetic. Not for human consumption or diagnostic use. For laboratory research only.

❓ Frequently Asked Questions (FAQs)

Q: What is the primary mechanism of action for Tirzepatide?

A: Tirzepatide is a first-in-class dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors . This balanced dual agonism synergistically improves glycemic control, suppresses appetite, and promotes weight loss.

Q: What is the structure of Tirzepatide?

A: Tirzepatide is a synthetic 39-amino acid peptide (sequence: YXEGTFTSDY SIXLDKIAQK AFVQWLIAGG PSSGAPPPS, where X is Aib) with a C20 fatty diacid moiety for extended half-life . Its molecular weight is approximately 4813.45 Da, and its CAS number is 2023788-19-2 .

Q: What are the most recent research findings on Tirzepatide (2025)?

A: Recent groundbreaking studies have demonstrated:

1. Type 1 Diabetes (Nov 2025): Tirzepatide induced 8.8% weight loss, improved HbA1c, and reduced insulin requirements by 35% in adults with type 1 diabetes and obesity .
2. Cellular Mode of Action (Aug 2025): Fluorescent markers (daLUXendins) visualized tirzepatide binding to pancreatic beta, alpha, and delta cells, and to appetite-regulating neurons and tanycytes in the brain .
3. Neuroprotection (Oct 2025): A comprehensive review highlighted tirzepatide's potential in addressing inflammation and oxidative stress in Alzheimer's and Parkinson's diseases .

Q: What is the difference between Tirzepatide and semaglutide?

A: Semaglutide is a selective GLP-1 receptor agonist. Tirzepatide is a dual GIP and GLP-1 receptor agonist. This dual mechanism has resulted in superior weight loss and glycemic control in head-to-head clinical trials .

Q: What is the half-life and bioavailability of Tirzepatide?

A: Tirzepatide has a plasma half-life of approximately 5 days, allowing for once-weekly subcutaneous administration. It is highly bound to plasma albumin (99%) .

Q: How do you verify the purity and identity of Tirzepatide?

A: We ensure every batch is rigorously analyzed using High Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) . HPLC confirms a purity level of ≥99% , while Mass Spectrometry verifies the precise molecular weight (~4813.45 Da) , ensuring the correct peptide structure and identity. Certificates of Analysis (COA) are available upon request.

Q: What are the critical storage conditions for Tirzepatide?

A: Store the lyophilized powder at -20°C (-4°F) or below, desiccated and protected from light and moisture; it is stable for up to 3 years under these conditions . Once reconstituted, aliquot and store at -20°C for long-term storage. Avoid repeated freeze-thaw cycles.

Q: Is Tirzepatide approved for clinical use?

A: Yes, tirzepatide is FDA-approved for type 2 diabetes (Mounjaro®) and chronic weight management (Zepbound®) . However, this product is sold strictly for laboratory research use only and is not intended for human consumption.

Q: Is Tirzepatide prohibited in sports research?

A: Researchers should be aware that tirzepatide, as a peptide hormone and metabolic modulator, would be considered a prohibited substance under the general category of peptide hormones and growth factors on the World Anti-Doping Agency (WADA) Prohibited List. It is intended for legitimate scientific research only.

Ready to Advance Your Research? 🚀

Equip your laboratory with a breakthrough dual agonist peptide for studying metabolic regulation, obesity, type 1 and type 2 diabetes, cardiovascular health, and neuroprotection. Order the high-purity Tirzepatide Peptide (GLP1-T) today from Buy Peptides Online USA. Benefit from our fast USA shipping, secure payments (including crypto), and the confidence that comes from rigorously tested, research-grade compounds validated by the latest 2025 discoveries . For any questions about this product or your order, our support team is here to provide technical consultation.